Skip to content

Study · Not a test of the peptide alone · 2002

3 results

[New approaches to antioxidant therapy in multiple sclerosis].

Odinak MM, Bisaga GN, Zarubina IV

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2002Cited by 3 (Europe PMC)

PMID12418396 (opens in a new tab)PepBankPUB-12418396
Publisher pageAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Cerebrolysin.

  1. 01HumanNot a test of Cerebrolysin aloneNon-randomized trialEfficacy outcome

    In relapsing-remitting multiple sclerosis, antioxidant regimens including a Cerebrolysin-containing combination reduced relapse frequency, especially in the combination group.

    In plain wordsIn multiple sclerosis patients, antioxidant regimens, including a Cerebrolysin combination, reduced relapses, especially in the combination group.

    Peptide
    Cerebrolysin
    Outcome
    DecreaseRelapse frequency
    Study

    n = 32

    Outcome group
    Neuroprotection · Nervous system and cognition

    Measurements

    Relapse frequency reduction
    2 to 3 times
    antioxidant treatment, especially group 2

    Source sentences

    Summary
    The treatment resulted in significant reduction (2-3 times) of relapse frequency in multiple sclerosis patients (especially in group 2) and decrease of required corticosteroid courses.
    1 context sentence
    Summary · context
    group 2 (14 patients) who received complex of antioxidants and neuroprotectors with various mechanisms of action (oc-lipoic acid, Nicotinamide, Acetylcysteine, Triovit Beta-carotine, Alpha-tocopheryl acetate, Ascorbic acid, Selenium, Pentoxifylline, Cerebrolysin, Amantadine hydrochloride)

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  2. 02HumanNot a test of Cerebrolysin aloneNon-randomized trialEfficacy outcome

    In relapsing-remitting multiple sclerosis, antioxidant regimens including a Cerebrolysin-containing combination decreased required corticosteroid courses.

    In plain wordsIn multiple sclerosis patients, antioxidant regimens, including a Cerebrolysin combination, reduced required corticosteroid courses.

    Peptide
    Cerebrolysin
    Outcome
    DecreaseRequired corticosteroid courses
    Study

    n = 32

    Outcome group
    Neuroprotection · Nervous system and cognition

    Source sentences

    Summary
    The treatment resulted in significant reduction (2-3 times) of relapse frequency in multiple sclerosis patients (especially in group 2) and decrease of required corticosteroid courses.
    1 context sentence
    Summary · context
    group 2 (14 patients) who received complex of antioxidants and neuroprotectors with various mechanisms of action (oc-lipoic acid, Nicotinamide, Acetylcysteine, Triovit Beta-carotine, Alpha-tocopheryl acetate, Ascorbic acid, Selenium, Pentoxifylline, Cerebrolysin, Amantadine hydrochloride)

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  3. 03HumanNot a test of Cerebrolysin aloneNon-randomized trialEfficacy outcome

    In multiple sclerosis patients, antioxidant therapy reduced lipid peroxide products, most strongly in the Cerebrolysin-containing combination group.

    In plain wordsIn multiple sclerosis patients, antioxidant therapy reduced lipid damage products, most strongly with the Cerebrolysin-containing combination.

    Peptide
    Cerebrolysin
    Outcome
    DecreaseLipid peroxide products
    Study

    n = 32

    Outcome group
    Oxidative stress · Whole body

    Source sentences

    Summary
    After antioxidant therapy the content of lipid peroxide products was significantly reduced (most expressed in group 2).
    1 context sentence
    Summary · context
    group 2 (14 patients) who received complex of antioxidants and neuroprotectors with various mechanisms of action (oc-lipoic acid, Nicotinamide, Acetylcysteine, Triovit Beta-carotine, Alpha-tocopheryl acetate, Ascorbic acid, Selenium, Pentoxifylline, Cerebrolysin, Amantadine hydrochloride)

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.